We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant

Delisted

PAVMZ was delisted on the 30th of April, 2025.

2 hedge funds and large institutions have $77 invested in PAVmed Inc. Series Z Warrant in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 42 (-2)

97% less capital invested

Capital invested by funds: $2.33K → $77 (-$2.26K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
1
UBS Group
Switzerland
$66
Bank of America
2
Bank of America
North Carolina
$11
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
-$2.13K -21,272 Closed
PNC Financial Services Group
4
PNC Financial Services Group
Pennsylvania
-$120 -1,000 Closed

PAVMZ Hedge Fund Activity: Q4 2023 in Review

2 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q4 2023, worth a combined $77 — down 97% from $2.33K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PAVMZ and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $2.13K sold.

  • 2 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q4 2023, down from 4 in Q3 2023.
  • Funds reported $77 of PAVmed Inc. Series Z Warrant stock for Q4 2023, down 97% quarter-over-quarter.
  • 0 funds opened new PAVmed Inc. Series Z Warrant positions in Q4 2023 and 2 closed out, a net change of -2 holders.
  • The largest PAVmed Inc. Series Z Warrant seller in Q4 2023 was Susquehanna International Group, an estimated $2.13K sold.

Based on aggregated 13F filings for Q4 2023.